Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50,436 | 47,052 | 22,649 | 37,811 | 16,712 |
| Marketable Securities | N/A | N/A | N/A | N/A | 599 |
| Receivables | N/A | N/A | N/A | N/A | 982 |
| Inventories | 1,626 | N/A | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 0 | 7,500 |
| TOTAL | $60,311 | $51,075 | $26,905 | $42,165 | $28,161 |
| Non-Current Assets | |||||
| PPE Net | 6,785 | 3,604 | 3,426 | 3,430 | 4,324 |
| Investments And Advances | 0 | 0 | 0 | 0 | 5,830 |
| Intangibles | 0 | 0 | 17,064 | 17,064 | 17,064 |
| Other Non-Current Assets | 6,617 | 7,560 | 6,197 | 6,936 | 8,864 |
| TOTAL | $13,402 | $11,164 | $26,687 | $27,430 | $36,082 |
| Total Assets | $73,713 | $62,239 | $53,592 | $69,595 | $64,243 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 970 | 24,025 | 41,675 | 757 |
| Accounts payable and accrued liabilities | 12,065 | 5,750 | 6,037 | 7,297 | 9,327 |
| Accrued Expenses | 10,209 | 11,064 | 11,008 | 14,807 | 29,308 |
| Other current liabilities | 393 | N/A | N/A | N/A | 2,830 |
| TOTAL | $22,667 | $17,784 | $41,070 | $63,859 | $42,302 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 2,985 | 4,206 | 1,861 | 2,907 |
| Deferred Revenues | 0 | N/A | N/A | 80 | 80 |
| Other Non-Current Liabilities | 4,954 | 259 | 194 | 22,031 | 142,499 |
| TOTAL | $4,641 | $2,985 | $4,206 | $23,879 | $145,599 |
| Total Liabilities | $27,308 | $20,769 | $45,276 | $87,738 | $187,901 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,981 | 4,532 | 3,003 | 2,054 | 1,073 |
| Common Shares | 1,872,885 | 1,744,801 | 1,579,866 | 1,418,931 | 1,188,071 |
| Retained earnings | -1,830,060 | -1,714,785 | -1,576,643 | -1,429,083 | -1,312,320 |
| Other shareholders' equity | 3,580 | 4,718 | 5,093 | -7,991 | 591 |
| TOTAL | $46,405 | $41,470 | $8,316 | $-18,143 | $-123,658 |
| Total Liabilities And Equity | $73,713 | $62,239 | $53,592 | $69,595 | $64,243 |